We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Click here

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
6,903.90
(
0.2%
)
S&P ASX All Technology
2,428.20
(
0.86%
)
Brent Oil
85.71
(
-5.53%
)
US Dollar vs AUD
1.58
(
-0.33%
)
Bitcoin
27,799.83
(
1.35%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ZyVersa Therapeutics Inc (ZVSA)

  7. ZyVersa Therapeutics Inc (ZVSA) News

ZVSA

ZyVersa Therapeutics (ZVSA)

ZyVersa Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZVSA
DateTimeSourceHeadlineSymbolCompany
04/10/202322:05GlobeNewswire Inc.ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to Attenuate Spread of Inflammation into Surrounding Tissues NASDAQ:ZVSAZyVersa Therapeutics Inc
27/09/202321:07GlobeNewswire Inc.ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases NASDAQ:ZVSAZyVersa Therapeutics Inc
22/09/202320:35GlobeNewswire Inc.ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues NASDAQ:ZVSAZyVersa Therapeutics Inc
21/09/202307:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend] NASDAQ:ZVSAZyVersa Therapeutics Inc
14/09/202321:00Edgar (US Regulatory)Form 8-K - Current report NASDAQ:ZVSAZyVersa Therapeutics Inc
14/09/202307:02Edgar (US Regulatory)Form ARS - Annual Report to Security Holders NASDAQ:ZVSAZyVersa Therapeutics Inc
14/09/202306:57Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material NASDAQ:ZVSAZyVersa Therapeutics Inc
14/09/202306:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements NASDAQ:ZVSAZyVersa Therapeutics Inc
12/09/202320:30GlobeNewswire Inc.ZyVersa Therapeutics Announces Research Published in Frontiers in Immunology Reinforcing IC 100’s Rationale for Inhibiting Multiple Inflammasomes to Control Inflammation in Various Inflammatory Diseases NASDAQ:ZVSAZyVersa Therapeutics Inc
09/09/202306:20Edgar (US Regulatory)Form 8-K - Current report NASDAQ:ZVSAZyVersa Therapeutics Inc
02/09/202306:45Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements NASDAQ:ZVSAZyVersa Therapeutics Inc
22/08/202306:15GlobeNewswire Inc.ZyVersa Therapeutics Reports Second Quarter 2023 Corporate and Financial Results NASDAQ:ZVSAZyVersa Therapeutics Inc
22/08/202306:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)] NASDAQ:ZVSAZyVersa Therapeutics Inc
19/08/202306:13Edgar (US Regulatory)Form 8-K - Current report NASDAQ:ZVSAZyVersa Therapeutics Inc
15/08/202322:26Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB NASDAQ:ZVSAZyVersa Therapeutics Inc
03/08/202321:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securities NASDAQ:ZVSAZyVersa Therapeutics Inc
27/07/202307:27Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)] NASDAQ:ZVSAZyVersa Therapeutics Inc
27/07/202307:11Edgar (US Regulatory)Form 8-K - Current report NASDAQ:ZVSAZyVersa Therapeutics Inc
27/07/202307:11Edgar (US Regulatory)Form 8-K - Current report NASDAQ:ZVSAZyVersa Therapeutics Inc
27/07/202306:21Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] NASDAQ:ZVSAZyVersa Therapeutics Inc
24/07/202322:00GlobeNewswire Inc.ZyVersa Therapeutics, Inc. Announces Pricing of $2.1 Million Public Offering NASDAQ:ZVSAZyVersa Therapeutics Inc
19/07/202314:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness NASDAQ:ZVSAZyVersa Therapeutics Inc
17/07/202321:38GlobeNewswire Inc.ZyVersa Therapeutics Announces Publication in the Journal, Hepatology, Highlighting the Role of NLRP3 Inflammasome-Mediated IL-18 in Development of Liver Fibrosis NASDAQ:ZVSAZyVersa Therapeutics Inc
14/07/202321:37GlobeNewswire Inc.ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 2nd Annual Kidney Conference to be Held Virtually on July 25, 2023 NASDAQ:ZVSAZyVersa Therapeutics Inc
10/07/202321:37GlobeNewswire Inc.ZyVersa Therapeutics Announces Publication in the Journal Circulation That Demonstrates the Role of Inflammasome Activation in Hypertrophic Heart Disease Induced by Mechanical Stress NASDAQ:ZVSAZyVersa Therapeutics Inc
08/07/202305:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] NASDAQ:ZVSAZyVersa Therapeutics Inc
07/07/202321:37GlobeNewswire Inc.European Patent Granted for ZyVersa Therapeutics' Lead Asset, Cholesterol Efflux Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease NASDAQ:ZVSAZyVersa Therapeutics Inc
01/07/202307:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] NASDAQ:ZVSAZyVersa Therapeutics Inc
28/06/202321:37GlobeNewswire Inc.ZyVersa Therapeutics Announces Publication in Clinical Immunology Demonstrating Association Between Renal NLRP3 Inflammasome Activation and Lupus Nephritis Disease Activity NASDAQ:ZVSAZyVersa Therapeutics Inc
21/06/202306:07GlobeNewswire Inc.ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD) NASDAQ:ZVSAZyVersa Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ZVSA
Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20231004 23:43:24